Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Waweru

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|October 25, 2008
Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmissionCatherine Waweru
Current Medical Research and Opinion|July 8, 2020
Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agentsCatherine Waweru, Simarjeet Kaur, Sheetal Sharma, et al.
Respiratory Investigation|April 3, 2026
Impact of timing of nontuberculous mycobacterial pulmonary disease antibiotic initiation on hospitalizations in JapanCatherine Waweru, Kozo Morimoto, Ping Wang, et al.
Leukemia & Lymphoma|May 6, 2021
Matching-adjusted indirect comparisons of safety and efficacy of acalabrutinib versus other targeted therapies in patients with treatment-naïve chronic lymphocytic leukemiaMatthew S Davids, Claire Telford, Sarang Abhyankar, et al.
Respiratory Medicine|October 9, 2025
Persistent use of amikacin liposome inhalation suspension associated with lower risk of hospitalizations and emergency room visits in refractory Mycobacterium avium complex lung diseaseKevin L Winthrop, Catherine Waweru, Emily Welch, et al.
ERJ Open Research|July 23, 2024
Reductions in hospitalisations and emergency department visits with early antibiotic initiation in nontuberculous mycobacterial lung diseaseKevin Winthrop, Catherine Waweru, Mariam Hassan, et al.
Pulmonary Therapy|November 14, 2025
Healthcare Resource Utilization in Refractory MACLD: Comparison of an Amikacin Liposome Inhalation Suspension (ALIS) Cohort with a Non-ALIS CohortTimothy R Aksamit, Catherine Waweru, Emily Welch, et al.
Health and Quality of Life Outcomes|October 8, 2014
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic ModuleJesús Cuervo, Nacho Castejón, Kristin M Khalaf, et al.
Journal of Medical Economics|April 19, 2017
Global health resource utilization associated with pacemaker complicationsCatherine Waweru, Anna Steenrod, Claudia Wolff, et al.
Journal of Medical Economics|January 4, 2018
Reply to: Brough CEP, Haycox A. Resource Use In Rectifying Pacemaker Complications. Journal of Medical Economics 2018. doi: 10.1080/13696998.2017.1423075Catherine Waweru, Anna Steenrod, Claudia Wolff, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|October 25, 2008
Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmissionCatherine Waweru
Current Medical Research and Opinion|July 8, 2020
Health-related quality of life and economic burden of chronic lymphocytic leukemia in the era of novel targeted agentsCatherine Waweru, Simarjeet Kaur, Sheetal Sharma, et al.
Respiratory Investigation|April 3, 2026
Impact of timing of nontuberculous mycobacterial pulmonary disease antibiotic initiation on hospitalizations in JapanCatherine Waweru, Kozo Morimoto, Ping Wang, et al.
Leukemia & Lymphoma|May 6, 2021
Matching-adjusted indirect comparisons of safety and efficacy of acalabrutinib versus other targeted therapies in patients with treatment-naïve chronic lymphocytic leukemiaMatthew S Davids, Claire Telford, Sarang Abhyankar, et al.
Respiratory Medicine|October 9, 2025
Persistent use of amikacin liposome inhalation suspension associated with lower risk of hospitalizations and emergency room visits in refractory Mycobacterium avium complex lung diseaseKevin L Winthrop, Catherine Waweru, Emily Welch, et al.
ERJ Open Research|July 23, 2024
Reductions in hospitalisations and emergency department visits with early antibiotic initiation in nontuberculous mycobacterial lung diseaseKevin Winthrop, Catherine Waweru, Mariam Hassan, et al.
Pulmonary Therapy|November 14, 2025
Healthcare Resource Utilization in Refractory MACLD: Comparison of an Amikacin Liposome Inhalation Suspension (ALIS) Cohort with a Non-ALIS CohortTimothy R Aksamit, Catherine Waweru, Emily Welch, et al.
Health and Quality of Life Outcomes|October 8, 2014
Development of the Incontinence Utility Index: estimating population-based utilities associated with urinary problems from the Incontinence Quality of Life Questionnaire and Neurogenic ModuleJesús Cuervo, Nacho Castejón, Kristin M Khalaf, et al.
Journal of Medical Economics|April 19, 2017
Global health resource utilization associated with pacemaker complicationsCatherine Waweru, Anna Steenrod, Claudia Wolff, et al.
Journal of Medical Economics|January 4, 2018
Reply to: Brough CEP, Haycox A. Resource Use In Rectifying Pacemaker Complications. Journal of Medical Economics 2018. doi: 10.1080/13696998.2017.1423075Catherine Waweru, Anna Steenrod, Claudia Wolff, et al.
Pageof 2